ヴァンザカフターとエレクサカフターに対する反応の違い
Noelia Rodriguez Mier1, Isabelle Callebaut2, Marijke Proesmans1
1Department of Development and Regeneration, Woman and Child Unit, CF research lab, KU Leuven, Leuven, Belgium; Department of Paediatrics, Paediatric Pulmonology, University Hospital Leuven, Leuven, Belgium.
No abstract available in PubMed .
さらに関連する動画
09:59Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein
Published on: March 9, 2015
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
関連する概念動画
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Bioequivalence of Drugs: Drugs with Multiple Indications
